Molecular Profiles to Host Industry Event
Pharmaceutical development and manufacturing services provider Molecular Profiles is set to host a seminar in the UK focused on overcoming biological barriers in drug development.
The UK-based company, a subsidiary of Columbia Laboratories, will launch the New Year by welcoming pharmaceutical executives and scientists from across the globe to the 2-day conference that aims to give an overview on the latest research in drug targeting and delivery for all routes of administration.
Keynote speakers already confirmed for the industry-led event include Professor Clive Wilson, Professor Jonathan Hadgraft, Professor Ijeoma Uchegbu and Professor Randy Mrsny.
Molecular Profiles’ chief technical officer Dr Robert Harris said: “We wanted to build upon the success of our event 2 years ago and mark the start of an exciting phase in the growth of our company with the opening of our new GMP facility by focussing on one of the key challenges in drug product development — overcoming the challenges of achieving bioavailability in the human body.
“The presentations will cover all aspects of drug delivery, from targeting to specific cells and locations in the body, to the advances in efficient delivery of drugs into the body.
“Our aim is to provide insight into these key areas of pharmaceutical research to help stimulate discussion and increase our knowledge and that of our attendees,” added Robert.
The conference is the second of its kind hosted by Molecular Profiles and will be held at the Belfry Hotel in Nottingham 21–22 January 2014.
Attendees will be given a tour of Molecular Profiles’ new clinical manufacturing facility, which opened last year prior to the company being acquired by Columbia Laboratories, a Boston-based company with a rich heritage in drug development.
Working with leading pharmaceutical companies across the globe, Molecular Profiles specialises in advanced characterisation, pharmaceutical product development, clinical trials manufacturing and analytical support. The company prides itself in its specialist knowledge in development of formulations for challenging molecules.
Its new clinical manufacturing facility enables the company to manufacture a range of dosage forms such as solids, liquids, semi-solids and inhaled products, including the capability for manufacture of highly potent compounds.
To attend the event, contact Ailsa Pearson at Molecular Profiles, Tel. +44 (0) 115 871 8887, [email protected]
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance